Article No
ABB-X3KOAE-100
Elafin/Skalp PI3
Anti-Elafin/Skalp PI3 Antibody (monoclonal, C7) . Tested in ELISA, IHC applications. This antibody reacts with Human.
Antibodies Primary
Specifications
| Application | ELISA, IHC |
| Article No | ABB-X3KOAE-100 |
| Biosite Brand | Biosite |
| Country Availability | all |
| Clone | C7 |
| Clone Type | monoclonal |
| Concentration | 500 ug/ml |
| Conjugation | Unconjugated |
| Cross Reactivity | No cross-reactivity with other proteins. |
| Description | Anti-Elafin/Skalp PI3 Antibody (monoclonal, C7) . Tested in ELISA, IHC applications. This antibody reacts with Human. |
| Supplier | Nordic Biosite |
| Entrez Gene ID | 5266 |
| Format | Lyophilized |
| Gene Symbol | PI3 |
| Immunogen | E. coli-derived human Elafin/Skalp recombinant protein (Position: A61-Q117). |
| Isotype | IgG1 |
| Localization | Secreted. |
| Notes | Anti-Elafin/Skalp PI3 Antibody (monoclonal, C7) . Tested in ELISA, IHC applications. This antibody reacts with Human. |
| Alias Names | Elafin; Elastase-specific inhibitor; ESI; Peptidase inhibitor 3; PI-3; Protease inhibitor WAP3; Skin-derived antileukoproteinase; SKALP; WAP four-disulfide core domain protein 14; PI3; WAP3; WFDC14 |
| Previous Article No | ABB-2183D9 |
| Product Type | Antibodies Primary |
| Protocol | Tested Species: In-house tested species with positive results. By Heat: Boiling the paraffin sections in 10mM citrate buffer, pH6.0, for 20mins is required for the staining of formalin/paraffin sections. Other applications have not been tested. Optimal dilutions should be determined by end users. |
| Purification | Affinity Purified |
| Shipping Information | BLUE ICE |
| Size | 100ug |
| Source / Host | mouse |
| Species Reactivity | human |
| Storage | -20°C, 4°C |
| Substrate / Buffer | Each vial contains 4mg Trehalose, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg NaN3. |
| Technical Specifications | Mouse IgG monoclonal antibody for Elafin/Skalp detection. Tested with IHC-P, ELISA(Cap) in Human. |
| UniProt Number | P19957 |
| Product Page Updated | 2024-04-17T08:16:15.165Z |
